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Objectives:  The  effect  of  type  2 diabetes  mellitus  (DM)  on  mortality  was  more  pronounced  in  women  than
men with  coronary  artery  disease  (CAD)  in  the  pre-stent  era  before  1996. However  this  relationship  is
controversial  in  the post-stent  era.
Methods:  We  studied  a cohort  of  1073  patients  with  angiographically  deﬁned  CAD from  the  Eastern
Taiwan  integrated  health  care  delivery  system  of  Coronary  Heart  Disease  (ET-CHD)  registry  during
1997–2003  in Tzu-Chi  General  Hospital,  Hualien,  Taiwan.  To  evaluate  gender-speciﬁc  DM  effect  on mor-
tality,  the  subjects  were  divided  into  4 groups:  diabetic  women  (n  =  147),  non-diabetic  women  (n =  127),
diabetic  men  (n =  239),  and  non-diabetic  men  (n = 560).  At  a  mean  follow-up  of 5.4 years,  cardiac  and
all-cause  mortality  were  the  primary  end  points.
Results: Annual  total  mortality  rates  were  10.2%,  5.1%,  7.2%,  and 4.8%;  annual  cardiac  mortality  rates
were  8.2%,  3.0%, 4.3%,  and  2.6%  for  diabetic  women,  non-diabetic  women,  diabetic  men,  and  non-diabetic
men,  respectively.  Multivariate  Cox  regression  models,  adjusted  for possible  confounders  showed  that
gender-speciﬁc  hazard  ratios  (HRs)  of DM  for total  mortality  were  2.02  (95%  CI: 1.32–3.09),  and  1.72  (95%
CI:  1.32–2.25)  for women  and men,  respectively.  The  HRs  for  total  mortality  associated  with  diabetes
were  not  different  between  women  and men  (p = 0.53).  Similarly,  adjusted  gender-speciﬁc  HRs  of  DM  for
cardiac mortality  were  2.46 (95%  CI: 1.45–4.19)  for women,  and  1.83 (95%  CI: 1.28–2.62)  for  men,  which
were  also not  signiﬁcantly  different  (p =  0.36).
Conclusions:  Among  patients  with  CAD,  the  impact  of DM  on  mortality  was  consistently  higher  in  women
than  in  men,  but  the differences  across  sexes  were  not  statistically  signiﬁcant  after  1996 in  Taiwan.
3  Jap© 201
ntroduction
Multiple evidence has demonstrated that patients with diabetes
ellitus (DM) but without Coronary Heart Disease (CHD) have
imilar risk for cardiac death as those with CHD but without DM
1]. Notably, a gender-based difference in mortality was observed
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among CHD patients, in whom women have a poorer prognosis
than men  [2]. There were some reasons to explain poor outcomes
in women  with CHD including older age, the presence of signiﬁcant
comorbidities, more severe clinical presentations, and higher rates
of in-hospital complications [3]. Additionally, in early registry stud-
ies before 1996 when coronary stents had not been widely applied,
the effect of DM on mortality was  more potent in women than
men with CHD [4–6]. In the pre-stent era, US national data indi-
cated that diabetic men  had a slower decline in CHD mortality than
non-diabetic men  while diabetic women were observed with an
increase in CHD mortality [7]. In contrast, many post-stent era stud-
ies after 1996 have shown the impact of DM on mortality in women
with CHD deﬁned by angiography lessening and without a signif-
icant difference in comparison with that in men [8–10]. However,
vier Ltd. All rights reserved.
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ome studies revealed the relationship still existing particularly in
atients with myocardial infarction or those undergoing coronary
rtery bypass grafting (CABG) surgery [11,12]. Therefore, the gen-
er differences in effects of DM on mortality may  be mediated by
atients’ baseline risk factors and treatments.
Accordingly, we assessed the gender-speciﬁc effects of DM on
ardiac and overall mortality, and investigated their differences in a
rospective cohort of 1073 patients with angiographically deﬁned
bstructive coronary artery disease (CAD). Patient characteristics
nd treatment data were collected at entry. The study cohort was
ollowed for an average of 5.4 years and the main outcome meas-
res were deaths from cardiac disease and any cause.
ethods
tudy subjects
Between January 1997 and December 2003, a cohort of 1347
atients was prospectively enrolled in the registry of “the Eastern
aiwan integrated health care delivery system of Coronary Heart
isease (ET-CHD)” at Tzu-Chi General Hospital, Hualien, Taiwan. At
nrollment, all study subjects were diagnosed to have obstructive
AD based on angiographic evidence of at least one major coronary
rtery or primary branch with a diameter stenosis of ≥50%. We
xcluded 40 patients with a prior cancer, and 234 subjects with
issing data for any adjustment covariate at baseline. Thus, the
nal sample size for this study was 1073 [13].
aseline assessments
Blood samples were drawn from study patients at the time of
oronary angiography. The clinical chemistry was measured by
U640e Chemistry Immuno Analyzer (AU640, Olympus, Tokyo,
apan). Each clinical chemical was measured using the reagents
or the AU640: SUA, OSR6136, uricase method; total choles-
erol, OSR6116, enzymatic; aminoantipyrene/phenol/peroxidase
ethod; high-density lipoprotein (HDL) cholesterol, OSR 6287,
irect-no pretreatment enzymatic immuno-inhibition method;
riglyceride, OSR6133, glycerol phosphate oxidase method; creat-
nine, OSR6178, modiﬁed Jaffe kinetic method, and urea nitrogen,
SR6234, urease/GLDH method. Diabetes mellitus was diagnosed
n patients with a history of antidiabetic or insulin medication or
asting blood glucose > 125 mg/dl at baseline. In addition, the pres-
nce of nephropathy was deﬁned as estimated glomerular ﬁltration
ate (eGFR) < 60 ml/min/1.73 m2 where the eGFR was  derived from
reatinine level and calculated by the Modiﬁcation of Diet in
enal Disease study equation [14]. Hypertension was diagnosed
n those with a history of antihypertensive drugs or baseline blood
ressure > 140/90 mmHg. The treatment procedure and medication
ere derived from hospital discharge records.
ndpoint
The survival status and cause of death were ascertained by
inkage to the mortality database until December 31, 2006. The
ortality database, submitted standardized certiﬁcates for each
eath, were mandatory for physicians by the Department of Health.
o the vital statistics published by the National Health Department
f Taiwan are complete, with a physician conﬁrmation rate of 99%.
his study was approved by the local Ethics Committee (IRB096-
9).tatistical analysis
To evaluate gender-speciﬁc DM effects on overall and cardiac
ortality, the subjects were divided into 4 groups: diabetic womenology 61 (2013) 393–398
(n = 147), non-diabetic women  (n = 127), diabetic men  (n = 239), and
non-diabetic men  (n = 560). Chi-square tests were used to test the
equality across the four study groups for categorical variables. Since
most continuous variables in this study did not follow a normal
distribution, Kruskal–Wallis test, a nonparametric method without
the requirement of normal assumption, was  used to determine the
difference among the 4 study groups. Kaplan–Meier survival curves
were plotted to depict the cardiac and overall mortality for the
study subjects over time. Cox proportional hazard regression mod-
els were used to determine the unadjusted and adjusted hazard
ratios (HRs) for cardiac and overall mortality associated with DM.
Gender by diabetes interaction terms were incorporated into the
Cox regression models to compare the equality of gender-speciﬁc
HRs for DM in all CAD patients as well as in subgroup analyses.
All statistical analyses were performed with SAS version 9.2 (SAS
Institute, Cary, NC, USA). A p < 0.05 was considered statistically sig-
niﬁcant.
Results
Table 1 shows the baseline characteristics of CAD patients
by gender and DM status. The average ages were 66.5 ± 7.9,
67.7 ± 10.2, 63.4 ± 11.5, and 65.4 ± 11.2 years for diabetic women,
non-diabetic women, diabetic men, and non-diabetic men, respec-
tively. At baseline, diabetic women  had higher proportions of
hypertension (82.3% vs 74.5%), diabetic nephropathy (53.7% vs
42.7%), low HDL-cholesterol (78.2% vs 51.5%), elevated triglycerides
(64.0% vs 55.2%), and 3-vessel disease (49.7% vs 46.4%) than did dia-
betic men. With regard to medications, aspirin was  prescribed to
all study patients and diuretics were mainly used for those with
heart failure or with a reduced left ventricular ejection fraction.
Therefore the presence of heart failure was  highly correlated with
diuretic use at entry (data not shown).
As of December 2006, there were 343 deaths including 207
(60.3%) cardiac deaths and 136 noncardiac deaths. The 136 noncar-
diac deaths were due to neoplasms (n = 31), cerebrovascular disease
(n = 21), respiratory system disease (n = 19), digestive system dis-
ease (n = 19), injury and poison (n = 13), renal and urinary system
disease (n = 9), infectious disease (n = 7), and other or unknown
causes (n = 17). Figs. 1 and 2 show the Kaplan–Meier survival curves
for total and cardiac mortality for the 4 study groups, respectively.
In both ﬁgures, the crossing of the survival curves indicates that the
risks for the overall and cardiac mortality changed over time across
the 4 groups. When controlling for DM status, for both patients with
and without DM,  the mortality risks of women  tended to decrease
and became lower than those of their male counterparts after year
7. As a result, the mortality gap between non-diabetic and diabetic
women diminished and became comparable to the gap for males
after year 7.
To reﬂect the crossing of the survival curves after year 7, we  con-
ducted the mortality and analyses for HRs by follow-up years of 7
(as of December 2003) and 10 (as of December 2007) in Table 2,
respectively. The mean (median) follow-up time was  3.17 (3.06)
years as of December 2003, and 5.36 (5.47) years as of December
2006. As of December 2003, annual total mortality rates were 15.4%,
5.8%, 6.8%, and 5.1% for diabetic women, non-diabetic women,
diabetic men, and non-diabetic men, respectively. However, as
reﬂected in survival curves, at the end of December 2006, the mor-
tality decreased considerably to 10.2% for diabetic women. The
changes of annual death in the other three groups were not as
drastic as that in diabetic women. The annual total mortality even
increased to 7.2% for diabetic men  (Table 2).
As of December 2003, multivariate Cox regression models,
adjusted for co-morbidities and possible confounders, showed that
gender-speciﬁc HRs of DM for total mortality were 2.81 (95% CI:
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Table  1
Baseline characteristics in coronary artery disease patients by gender and diabetic status.
Variables Totaln = 1073 DM femalen = 147 Non-DM femalen = 127 DM malen = 239 Non-DM malen = 560 p-Value
Age (years) 65.4 ± 10.8 66.5 ± 7.9 67.7 ± 10.2 63.4 ± 11.5 65.4 ± 11.2 0.009
BMI  (kg/m2) 25.5 ± 3.6 25.4 ± 3.7 25.5 ± 3.7 26.1 ± 3.9 25.3 ± 3.4 0.035
Systolic blood pressure (mmHg) 132.4 ± 19.9 134.6 ± 20.0 133.7 ± 22.2 133.2 ± 20.9 131.2 ± 18.8 0.193
Diastolic blood pressure (mmHg) 77.1 ± 12.2 75.7 ± 12.1 76.8 ± 12.5 78.4 ± 13.0 77.0 ± 11.9 0.471
Smoking status (%)
Nonsmoker 48.0 84.4 81.9 37.7 35.2
<0.001Ex-smoker 16.3 4.1 6.3 20.1 20.2
Current smoker 35.7 11.6 11.8 42.3 44.6
Hypertension (%) 69.2 82.3 72.4 74.5 62.7 <0.001
Stroke (%) 9.3 13.6 3.9 11.3 8.6 0.029
Laboratory ﬁndings
Total cholesterol (mg/dl) 190.0 ± 46.2 198.0 ± 51.6 196.1 ± 40.4 188.1 ± 46.3 187.3 ± 45.7 0.021
Hypercholesterolemia (≥200, %) 38.8 46.9 43.3 38.5 35.7 0.059
HDL-C (mg/dl) 42.4 ± 11.4 43.3 ± 11.8 48.9 ± 12.1 40.4 ± 10.5 41.6 ± 10.9 <0.001
Abnormal HDL-Ca (%) 52.4 78.2 57.5 51.5 44.8 <0.001
Triglyceride (mg/dl) 172.3 ± 118.1 220.3 ± 136.2 141.0 ± 78.0 201.8 ± 147.4 154.2 ± 98.8 <0.001
Hypertriglyceridemia (≥150, %) 46.4 64.0 33.1 55.2 41.1 <0.001
LDL-C  (mg/dl) 114.6 ± 38.8 111.8 ± 37.6 119.6 ± 36.4 109.7 ± 37.7 116.2 ± 39.9 0.138
Abnormal LDL (≥130, %) 29.9 28.2 32.0 27.3 30.8 0.702
Fasting glucose (mg/dl) 143.3 ± 72.3 220.2 ± 101.6 108.1 ± 20.2 195.6 ± 76.4 108.7 ± 23.7 <0.001
Creatinine (mg/dl) 1.3 ± 0.9 1.3 ± 0.7 1.0 ± 0.8 1.5 ± 1.0 1.3 ± 0.8 <0.001
eGFR  < 60 ml/min/1.73 m2 (%) 43.3 53.7 42.5 42.7 41.1 0.052
Blood  urea nitrogen (mg/dl) 21.3 ± 10.3 24.7 ± 12.0 18.1 ± 6.9 22.8 ± 12.4 20.6 ± 9.0 <0.001
Uric  acid (mg/dl) 6.9 ± 2.2 6.9 ± 2.5 6.5 ± 2.2 6.7 ± 2.1 7.0 ± 2.1 0.007
Clinical presentation
Diseased vessels (%)
Single-vessel 38.5 30.6 46.5 29.3 42.7
<0.001Double-vessel 21.2 19.7 13.4 24.3 22.0
Triple-vessel 40.4 49.7 40.2 46.4 35.4
Myocardial infarction (%) 42.0 36.1 32.3 41.4 46.1 0.012
Treatment
PCI  (%) 53.6 49.7 49.6 53.1 55.7 0.430
CABG  (%) 24.0 29.9 26.0 25.1 21.6 0.170
Medication at enrollment
Diuretic (%) 22.2 28.6 19.7 27.2 18.9 0.013
Calcium channel blockers (%) 40.7 38.1 47.2 39.3 40.5 0.414
ACE  inhibitor (%) 50.1 57.1 51.2 53.1 46.8 0.097
Beta-blocker (%) 38.8 40.1 38.6 43.5 36.4 0.299
Statin  (%) 16.9 19.7 14.2 17.6 16.4 0.642
p-Values were derived from chi-square or Kruskal–Wallis test.
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mM,  diabetes mellitus; BMI, body mass index; HDL-C, high-density lipoprotein ch
ercutaneous coronary intervention; CABG, coronary artery bypass grafting; ACE, a
a Abnormal HDL-C was  deﬁned as HDL-C < 40 mg/dl for males and HDL-C < 50 mg.70–4.65), and 1.51 (95% CI: 1.06–2.15) for women and men,
espectively. Diabetic women had a signiﬁcantly higher HR than
iabetic men  (p = 0.04). For cardiac mortality, adjusted gender-
peciﬁc HRs associated with DM were 2.98 (95% CI: 1.58–5.62) for
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ig. 1. Kaplan–Meier survival curves for overall mortality by gender and diabetes
ellitus (DM) status in coronary artery disease patients.rol; LDL, low-density lipoprotein; eGFR, estimated glomerular ﬁltration rate; PCI,
nsin-converting enzyme.
 females.
women, and 1.72 (95% CI: 1.08–2.74) for men. The diabetic HR in
women was  still higher than that in men  though not signiﬁcant
(p = 0.10). As of December 2006, the adjusted HR associated with
DM for total and cardiac mortality in women decreased to 2.02
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Fig. 2. Kaplan–Meier survival probabilities without cardiac death by gender and
diabetes mellitus (DM) status in coronary artery disease patients.
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Table 2
Gender-speciﬁc DM hazard ratios for total and cardiac mortality in coronary artery disease patients.
Study group Event (n) Annual mortality (%) Crude HR (95% CI) Adjusted HRa (95% CI) p-Value&
Follow-up to December 2003
All-cause mortality
DM female (n = 147) 58 15.41 2.70 (1.68–4.36) 2.81 (1.70–4.65)
Non-DM female (n = 127) 24 5.76 1 1 0.04
DM  male (n = 239) 49 6.77 1.31 (0.93–1.85) 1.51 (1.06–2.15)
Non-DM male (n = 560) 96 5.10 1 1
Cardiac mortality
DM female (n = 147) 46 12.22 3.56 (1.95–6.50) 2.98 (1.58–5.62)
Non-DM female (n = 127) 14 3.36 1 1 0.10
DM  male (n = 239) 31 4.28 1.61 (1.03–2.53) 1.72 (1.08–2.74)
Non-DM male (n = 560) 49 2.60 1
Follow-up to December 2006
All-cause mortality
DM female (n = 147) 65 10.24 1.97 (1.31–2.98) 2.02 (1.32–3.09) 0.53
Non-DM female (n = 127) 36 5.08 1 1
DM male (n = 239) 89 7.23 1.49 (1.15–1.94) 1.72 (1.32–2.25)
Non-DM male (n = 560) 153 4.82 1 1
Cardiac mortality
DM female (n = 147) 52 8.19 2.71 (1.63–4.51) 2.46 (1.45–4.19) 0.36
Non-DM female (n = 127) 21 2.96 1 1
DM male (n = 239) 53 4.31 1.68 (1.18–2.37) 1.83 (1.28–2.62)
Non-DM male (n = 560) 81 2.55 1. 1
HR, hazard ratio; DM,  diabetes mellitus.
a Adjusted for age, smoking status, HDL cholesterol, non-HDL cholesterol, creatinine, stroke, number of blocked coronary artery, myocardial infarction, percutaneous
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portions of comorbidities, severe CAD, and treatment with coronaryoronary intervention, coronary artery bypass grafting, and medication status (diur
& p for sex comparison of adjusted hazard ratios.
95% CI: 1.32–3.09) and 2.46 (95% CI: 1.45–4.19), respectively. The
hanges of HRs in male patients were not as noticeable as those in
emales; HR, 1.72 (95% CI: 1.32–2.25) for total mortality, and 1.83
95% CI: 1.28–2.62) for cardiac mortality. Therefore, at 10 years of
ollow-up, although the diabetic HRs for mortality were higher in
omen than in men, the gender differences in HRs lessened over
ime and were not signiﬁcant (p = 0.53 for overall mortality, and
 = 0.36 for cardiac mortality) (Table 2). Adjusted survival curves
or overall mortality by gender and DM status are depicted in sup-
lemental material (S-Fig. 1).
Supplementary material related to this article found, in the
nline version, at http://dx.doi.org/10.1016/j.jjcc.2013.02.007.
Table 3 presents gender-speciﬁc HRs for total mortality asso-
iated with DM in various subgroups of CAD patients at 10 years
f follow-up. The diabetic HRs in women were consistently higher
han in men, although the sex comparisons were not signiﬁcant.
he most striking gender difference was noted in patients treated
ith CABG (adjusted HR of 4.10 in women and 1.45 in men, p = 0.05
or the comparison).
able 3
ender speciﬁc diabetes mellitus hazard ratios for total mortality in subgroups of corona
n Crude HR (9
MI  subgroup 
Female 94 1.64 (0.91–2
Male 357 1.55 (1.07–2
Subgroup without MI  
Female 180 2.30 (1.30–4
Male 442 1.50 (1.04–2
Treatment with CABG 
Female 77 2.87 (1.22–6
Male 181 1.25 (0.73–2
Treatment with PCI
Female 127 1.46 (0.80–2
Male  409 1.26 (0.83–1
Medical therapy only 
Female 70 2.39 (1.10–5
Male 209 2.09 (1.33–3
ABG, coronary artery bypass graft; HR, hazard ratio; MI  myocardial infarction; PCI, percu
* p for sex comparison of adjusted hazard ratios.alcium channel blockers, angiotensin-converting enzyme inhibitors, statins).
Discussion
In the ET-CHD registry, the mortality impact of DM was  consis-
tently higher in women than in men, but the differences between
sexes were not statistically signiﬁcant in a 10-year follow-up study
after 1996. In subgroup analysis, diabetic women had even higher
risks for mortality if they were observed in a shorter duration
(before year 7) or those undergoing CABG. The greatest strength
in our report is that the Buddhist Tzu-Chi General Hospital was the
only cardiovascular referral center in Hualien and Taitung, two of
the largest counties in Taiwan to carry out angiography for patients
with symptomatic CAD from 1997 to 2003. Therefore, the selection
bias for low-risk patients with obstructive CAD could be largely
eliminated, and instead this reﬂected that there were higher pro-ry artery disease patients.
5% CI) Adjusted HR (95% CI) p-Value*
0.95
.96) 1.92 (1.03–3.57)
.24) 1.88 (1.27–2.71)
0.27
.06) 2.02 (1.11–3.66)
.18) 1.37 (0.93–2.02)
0.05
.73) 4.10 (1.68–9.99)
.14) 1.48 (0.83–2.65)
.66) 1.44 (0.78–2.68) 0.95
.90) 1.41 (0.90–2.20)
0.96
.18) 2.22 (0.94–5.27)
.26) 2.18 (1.34–3.54)
taneous coronary intervention.
interventions in the ET-CHD cohort than other CAD cohorts by
angiography worldwide [8–10]. Consistent with previous reports,
CAD patients with DM had more underlying diseases and complex
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oronary anatomy at baseline and were associated with a higher
isk for deaths at follow-up than non-diabetic ones [10–12].
Epidemiological ﬁndings have shown that diabetic women
end to be older and have a higher risk for hypertension, lower
DL-cholesterol, higher triglyceride, and greater lipid peroxida-
ion, independent of glycemic control than diabetic men  [15–18].
esides, diabetic women have greater adverse effects with regard to
aist-to-hip ratio, low-density lipoprotein- and HDL-cholesterol,
ow-density lipoprotein particle size, apolipoprotein A1 and B, as
ell as ﬁbrinogen. Furthermore, the relationship between DM and
ndothelial function may  vary between sexes, and DM is a predictor
f endothelial dysfunction in women, while obesity is more impor-
ant to endothelial dysfunction in men  [19]. Biologically, excess
irculating glucose may  decrease vascular and platelet nitric oxide
roduction, thereby enhancing vascular tone, platelet aggregation,
nd vascular proliferation that adversely attenuates the estrogen-
elated cardiovascular protection [20–22].
With the improving knowledge for acute coronary syndrome
reatment after 1996, the gender differences in mortality after
yocardial infarction have gradually reduced [8–10]. As in our ﬁnd-
ngs, the relative risk for all-cause mortality between diabetic and
on-diabetic women was insigniﬁcantly higher than men  among
hose with myocardial infarction or undergoing percutaneous coro-
ary intervention (PCI) [23]. In contrast, the gender difference
n DM inﬂuence on overall mortality was marginally signiﬁcant
or patients with CABG (p = 0.054). In previous reports, women
ndergoing CABG were also found to have more comorbidities
t entry and more crude post-operative deaths than men. How-
ver, after multivariate adjustments, the results regarding whether
eing female is a predictor of post-operative death were conﬂicting
24–26]. Moreover, the gender-speciﬁc mortality associated with
M has rarely been studied. In a CABG subgroup analysis from the
lberta Provincial Project for Outcomes Assessment in Coronary
eart Disease (APPROACH) registry, the effect of DM on mortal-
ty demonstrated no signiﬁcant difference between women  and
en over a 4-year follow-up [10]. In comparison with our CABG
ohort, in a 7-year follow-up (1997–2003), the diabetic HR in mor-
ality was 4.05 (95% CI: 1.54–10.66) for women and 1.29 (95% CI:
.61–2.72) for men, p = 0.06 for sex comparison. Therefore, the dis-
arity between these two registries should be further clariﬁed.
Another novel ﬁnding in the ET-CHD cohort is that the risk for
ardiac and all-cause deaths in diabetic women was prominent in
 shorter follow-up period (1997–2003) and attenuated in a longer
ollow-up period (1997–2006). However, this phenomenon was
ot seen in diabetic men, non-diabetic women and men  who had a
teady increase in their annual risks of death. As we know, women
sually presented with atypical features of acute coronary syn-
rome and deferred for primary coronary interventions resulting in
orse outcomes [11]. In contrast to the Coronary REvascularization
emonstrating Outcome study in Kyoto (CREDO-Kyoto) registry,
apanese women had a lower incidence of all-cause mortality
elative to men  in a long-term follow-up after ﬁrst coronary revas-
ularization [27]. This disparity may  be caused by ethnic difference
nd better medical adherence in Japanese women. In addition, the
ardiac death among diabetic women was highly related to the
uration of DM. In the 1971–1992 National Health and Nutrition
xamination Survey Epidemiologic Follow-up Study [28], recent
M and long-standing DM were associated with as high a risk for
HD death as myocardial infarction in men. In women, although
ecent DM had a CHD mortality risk similar to myocardial infarc-
ion, long-standing DM had an even greater risk. Therefore, more
iabetic women with long-standing DM caused a higher proportion
f diabetic nephropathy and higher mortality in them compared
ith the other groups in our study.
Finally, this study has some limitations to be addressed.
irst, only 79.6% patients had complete records of all pre-set
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laboratory examinations. Despite that, there was  no signiﬁcant
change in all adjustment variables after the patients with missing
data were taken into account. Second, we could not adjust some
possible confounding factors at entry due to pre-existing database
such as the severity of heart failure. Third, the duration of DM,
the change in anti-diabetic agents, and status of glycemic control
(HbA1c) in the cohort could not be acquired in our study. However,
the incidence of DM death in both non-diabetic women and men
were reported less than 0.5% from 1997 to 2006, which reinforces
the impact of DM on mortality in diabetic patients to non-diabetic
ones who  rarely developed new-onset DM during the follow-up.
In conclusion, among patients with obstructive CAD, the impact
of DM on mortality between women and men  was not signiﬁ-
cantly different after 1996 in eastern Taiwan. In subgroup analysis,
diabetic women may  have the highest risk for cardiac and total
mortality in a shorter follow-up time or those undergoing CABG.
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